MB Holding Company LLC
Home  l  Contact Us  l  Site map  l  Search

MB Holding Company LLC

NewsReview   l   Press Release

Pr ess Release

Petrogas E&P supports the National Breast Cancer Genetic Testing Programme at Royal Hospital

As part of its on-going efforts to aid scientific research and development which in turn will benefit the Omani society, Petrogas E&P, the exploration & production arm of MB Holding Group lent its support to the recently established National Breast Cancer Genetic Testing Programme at Royal Hospital.

Through this programme, the hospital aims to improve breast cancer treatment & management, screening & risk management strategies of breast associated mutations as well as decrease genetic costs associated with international laboratories. The contribution by Petrogas E&P will be utilized to purchase reagent kits and consumables required to carry out genetic tests on up to 50 patients with young age and/or strong history of breast cancer.

Breast cancer is the most prevalent cancer in Oman. Although majority of breast cancers occur sporadically, breast cancers can also occur due to inherited genetic mutations. Clinicians in Oman are noting increasing numbers of breast cancer cases among young women below the age of 40. Moreover, in Oman, the peak age-range of breast cancer patients is between 41-50 years. This is in stark contrast to Western countries where the peak range is 60-70 years. Hence, it is important to use genetic testing to assess cancer risk in patients and their families as this has important implications for their treatment and cancer surveillance.

On the occasion of unveiling the programme, Iman Al Barwani, Manager – Corporate Communications & CSR, Petrogas E&P, said, “One of the best ways to beat cancer is early detection & diagnosis coupled with personalized medical management. The National Genetic Testing Center intends to do the same thereby reducing the overall cost of the national healthcare system. It will also give women who are genetically predisposed a chance to early detection and cure.”

Dr Anna Rajab, Director, National Genetic Centre, added, “We are very thankful to Petrogas E&P for partnering with us in this initiative. The involvement of corporates in such initiatives is both beneficial and heartwarming as their contributions help us provide better and up-to-date services and screening facilities to our patients. We encourage more corporates to take the lead from Petrogas E&P and help us in building a healthy breast cancer free nation.”

Established in 1999, Petrogas E&P is the holding company for MB Group’s Exploration and Production (E&P) assets in Oman, India and Egypt. Petrogas E&P subsidiaries are engaged in the full range of Oil & Gas activities from exploration through appraisal, development and production.


MB Holding Company LLC

© 2013, MB Holding Company LLC